NEW YORK (
) hit a new 52-week low Wednesday as it is currently trading at $2.30, below its previous 52-week low of $2.31 with 271,560 shares traded as of 10:25 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Merge Healthcare has a market cap of $235.2 million and is part of the
industry. Shares are down 47.4% year to date as of the close of trading on Tuesday.
Merge Healthcare Incorporated provides healthcare information technology solutions in the United States and internationally. Its software solutions automate healthcare data and diagnostic workflow to create an electronic record of the patient experience. The company has a P/E ratio of 3.7, below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Merge Healthcare as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally poor debt management and weak operating cash flow. You can view the full
or get investment ideas from our